基金经理：刘海燕
| 单位净值:0.8747 | 净值增长率:1.38% | 累计净值:0.8747 | 截止日期:2026/10/9 | ||
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:0.06亿元 | 风险等级:高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
富国国证疫苗与生物科技ETF发起式联接C(021281)申购赎回 |
||||||
|---|---|---|---|---|---|---|
| 报告期 | 期初总份额(份) | 期末总份额(份) | 期间总申购份额(份) | 期间总赎回份额(份) | 期间净申赎份额(份) | 净申赎比例 |
| 2026/6/30 | 4,522,140 | 6,434,940 | 21,360,100 | 19,447,300 | 1,912,800 | 42.3% |
| 2026/6/30 | 7,012,760 | 6,434,940 | 5,398,630 | 5,976,450 | -577,820 | -8.24% |
| 2026/3/31 | 4,522,140 | 7,012,760 | 15,961,500 | 13,470,900 | 2,490,600 | 55.08% |
| 2025/12/31 | 167,230 | 4,522,140 | 19,318,900 | 14,964,000 | 4,354,900 | 2604.14% |
| 2025/12/31 | 1,622,560 | 4,522,140 | 6,721,050 | 3,821,470 | 2,899,580 | 178.7% |
| 2025/9/30 | 424,723 | 1,622,560 | 8,708,260 | 7,510,430 | 1,197,830 | 282.03% |
| 2025/6/30 | 167,230 | 424,723 | 3,889,580 | 3,632,080 | 257,500 | 153.98% |
| 2025/6/30 | 539,682 | 424,723 | 2,150,400 | 2,265,360 | -114,960 | -21.3% |
| 2025/3/31 | 167,230 | 539,682 | 1,739,180 | 1,366,720 | 372,460 | 222.72% |
| 2024/12/31 | 2,020 | 167,230 | 697,095 | 531,885 | 165,210 | 8178.71% |
| 2024/12/31 | 36,363 | 167,230 | 413,745 | 282,878 | 130,867 | 359.89% |
| 2024/9/30 | 24,266 | 36,363 | 179,029 | 166,931 | 12,098 | 49.86% |
| 2024/6/30 | 2,020 | 24,266 | 104,322 | 82,076 | 22,246 | 1101.27% |
| 2024/6/30 | 2,020 | 24,266 | 104,322 | 82,076 | 22,246 | 1101.27% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。